IP Library Granted Patent US 9,770,576
Granted Patent B2
US 9,770,576 · App. 14/932,033 · Granted Sep 26, 2017

Methods and apparatuses for coating balloon catheters

Inventors: Jeffrey Wang (Chanhassen, MN); Harrison Malinoff (Minneapolis, MN); Lixiao Wang (Medina, MN); Christopher M. Barry (Medina, MN); Dennis W. Wahr (Minnetonka, MN); Scott R. Naisbitt (Minneapolis, MN)
Assignee: Lutonix, Inc.
A61M25/1029A61M25/1038B05D1/002B05D1/26B05D3/0493B05D3/107B05D5/00A61M2025/105A61M2025/1031A61M2025/1088
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,770,576
App. No.
14/932,033
Granted
Sep 26, 2017
Kind
B2
Abstract

Methods and apparatus for coating a medical device are provided. In one embodiment, the method for preparing a substantially uniform coated medical device includes (1) preparing a coating solution comprising a solvent, a therapeutic agent, and an additive; (2) loading a metering dispenser with the coating solution; (3) rotating the medical device about the longitudinal axis of the device and/or moving the medical device along the longitudinal or transverse axis of the device; (4) dispensing the coating solution from the metering dispenser onto a surface of the medical device and flowing the coating solution on the surface of the medical device while the medical device is rotating and/or linearly moving; and (5) evaporating the solvent, forming a substantially uniform coating layer on the medical device.

Claims (42)

1. A method for preparing a substantially uniformly coated medical device, comprising:

(1) preparing a coating solution consisting of a solvent, a therapeutic agent, and an additive, wherein;

the therapeutic agent is chosen from paclitaxel, rapamycin, daunorubicin, doxorubicin, lapachone, vitamin D2, vitamin D3, and combinations thereof;

the solvent is chosen from water, methanol, ethanol, isopropanol, acetone, dimethylformamide, tetrahydrofuran, methylethyl ketone, dimethylsulfoxide, acetonitrile, ethyl acetate, chloroform, and mixtures thereof; and

the additive is chosen from sorbitol, octanoyl-N-methylglucamide, gluconolactone, lactobionic acid, a poly(ethylene glycol) sorbitan fatty ester, or a combination thereof;

(2) loading a metering dispenser with the coating solution;

(3) rotating the medical device about the longitudinal axis of the medical device and/or moving the medical device in a linear direction along the longitudinal or transverse axis of the medical device;

(4) dispensing the coating solution from the metering dispenser onto a surface of the medical device and flowing the coating solution on the surface of the medical device while the medical device is rotating and/or linearly moving; and

(5) evaporating the solvent, forming a substantially uniform coating layer on the medical device.

2. The method of claim 1 , wherein the method further comprises:

(6) sterilizing the medical device; and

(7) drying the medical device after sterilization.

3. The method of claim 1 , wherein the medical device is chosen from a balloon catheter, a perfusion balloon catheter, an infusion catheter, a perforated balloon, a spaced double balloon, a porous balloon, a weeping balloon, a cutting balloon catheter, a scoring balloon catheter, a laser catheter, an atherectomy device, a debulking catheter, a stent, a filter, a stent graft, a covered stent, a patch, a wire, and a valve.

4. The method of claim 1 , wherein the medical device is chosen from a balloon catheter, a perfusion balloon catheter, a perforated balloon, a spaced double balloon, a porous balloon, a weeping balloon, a cutting balloon catheter, or a scoring balloon catheter.

5. The method of claim 1 , wherein the medical device is a balloon catheter.

6. The method of claim 1 , wherein at least steps (4) and (5) are repeated until the from 1 μg/mm 2 to 20 μg/mm 2 of the therapeutic agent in the coating is deposited on the surface of the medical device.

7. The method of claim 1 , wherein in step (7) the medical device is dried under vacuum at from 5° C. to 60° C. for about 1 hour to 120 hours.

8. The method of claim 1 , wherein in step (7) the medical device is dried under vacuum at from 5° C. to 45° C. for about 2 hours to 56 hours.

9. The method of claim 1 , wherein:

the therapeutic agent comprises paclitaxel;

the solvent is chosen from mixtures of water and ethanol, mixtures of water and acetone, mixtures of water and methanol, and mixtures of water and ethanol and acetone; and

the additive comprises poly(ethylene glycol)-20 sorbitan monolaurate.

10. The method of claim 9 , wherein the medical device is chosen from a balloon catheter, a perfusion balloon catheter, a perforated balloon, a spaced double balloon, a porous balloon, a weeping balloon, a cutting balloon catheter, or a scoring balloon catheter.

11. The method of claim 9 , wherein the medical device is a balloon catheter.

12. The method of claim 1 , wherein:

the therapeutic agent comprises paclitaxel;

the solvent is chosen from mixtures of water and ethanol, mixtures of water and acetone, mixtures of water and methanol, and mixtures of water and ethanol and acetone; and

the additive comprises sorbitol.

13. The method of claim 12 , wherein the medical device is chosen from a balloon catheter, a perfusion balloon catheter, a perforated balloon, a spaced double balloon, a porous balloon, a weeping balloon, a cutting balloon catheter, or a scoring balloon catheter.

14. The method of claim 12 , wherein the medical device is a balloon catheter.

15. The method of claim 1 , wherein:

the therapeutic agent comprises paclitaxel;

the solvent is chosen from mixtures of water and ethanol, mixtures of water and acetone, mixtures of water and methanol, and mixtures of water and ethanol and acetone; and

the additive comprises a mixture of poly(ethylene glycol)-20 sorbitan monolaurate and sorbitol.

16. The method of claim 15 , wherein the medical device is chosen from a balloon catheter, a perfusion balloon catheter, a perforated balloon, a spaced double balloon, a porous balloon, a weeping balloon, a cutting balloon catheter, or a scoring balloon catheter.

17. The method of claim 15 , wherein the medical device is a balloon catheter.

18. The method of claim 1 , wherein:

the therapeutic agent comprises paclitaxel;

the solvent is chosen from mixtures of water and ethanol, mixtures of water and acetone, mixtures of water and methanol, and mixtures of water and ethanol and acetone; and

the additive comprises gluconolactone.

19. The method of claim 18 , wherein the medical device is chosen from a balloon catheter, a perfusion balloon catheter, a perforated balloon, a spaced double balloon, a porous balloon, a weeping balloon, a cutting balloon catheter, or a scoring balloon catheter.

20. The method of claim 18 , wherein the medical device is a balloon catheter.

Continuity (4)
Continuation 13846358 · Mar 18, 2013
Continuation 12549180 · Aug 27, 2009
Provisional Application 61092872 · Aug 29, 2008
Related Publication 20160067462A1 · Mar 10, 2016